Pioneering Medicines, a division of Flagship Pioneering, is looking to harness the power of Flagship's scientific platforms to create novel treatment options that benefit more patients, sooner, by addressing serious diseases with unmet medical need.
Requirements
- Basic scientific training and/or recognized scientific expertise in a relevant field.
- Clinical experience and clinical development experience are advantageous but not required.
- Highly resourceful and effective in uncertain circumstances.
- Strong prioritization and adaptive synthesis skills.
- Comfortable venturing into new scientific and clinical spaces.
- Willingness to consider unconventional approaches to challenging problems.
- Proven ability to work collaboratively within and across functions and teams.
Responsibilities
- Lead and contribute to high-impact product explorations across various therapeutic areas each year.
- Generate and refine transformative clinical outcomes, proposing scopes and objectives for each exploration.
- Collaborate with a small team to generate diverse product concepts, subjecting ideas to rigorous validation and expert critique.
- Define and articulate selected product concepts, detailing the platform capabilities and technologies required.
- Engage in the prioritization process of compelling concepts for development into ProtoCos.
- Build and maintain strong relationships across Flagship and its platform companies to understand their capabilities.
- Balance creative and unconstrained thinking with structured exploration methods designed to achieve transformational clinical outcomes.
Other
- Medical Degree (MD or DO or equivalent), PhD, or MD/PhD with significant research experience, including peer-reviewed publications.
- Leadership skills to guide teams through complex explorations and influence team decisions.
- Excellent written and verbal communication skills, with good conflict resolution capabilities.
- Ability to distill and synthesize information for varied audiences.
- Entrepreneurial spirit and mission-oriented towards breakthrough therapies.
